Many drugs used in anaesthesia may prolong the QT interval of the electrocardiogram (ECG), and recent U.S. Food and Drug Administration guidelines mandate monitoring of the ECG before, during and after droperidol admini stration. We surveyed 41 trainee and consultant anaesthetists in our Department to determine current practice and knowledge of the QT interval to investigate if this is a practical proposition. A response rate of 98% (40/41) was obtained. The majority of respondents expressed moderate to high levels of confidence in interpreting the ECG, and this was related to years of training (rho 0.36, P=0.024). A total of 27 respondents (65%) were able to correctly identify the QT interval on a schematic representation of the ECG, trainees 70% vs consultants 60%, P=0.51. When asked to name drugs that altered the QT interval, droperidol was included by 11 of the 40 respondents (28%); trainees 10% vs consultants 45%, OR 7.4 (95% CI: 1.341), P=0.013. Torsades de Pointes was correctly identified as a possible consequence of a prolonged QT interval by 65% of trainees and 70% of consultants, P=0.83. The results suggest that QT interval measurement is not widely practised by anaesthetists, although its clinical significance is well known, and interpretation would be unreliable without further education.
The QT interval, timed from the beginning of the Q wave to the end of the T wave, is an important component of the electrocardiogram (ECG) signifying the duration of ventricular depolarization and repolarization. QT interval prolongation may occur in a variety of disease states or as part of a genetic abnormality of potassium or more rarely, sodium channels 1, 2 . Acquired causes of QT prolongation include general anaesthesia, stroke, hypothermia, multi-organ failure, starvation, or following administration of a wide range of medications [3] [4] [5] . QT prolongation predisposes to spontaneous occurrence of polymorphic ventricular tachycardia (Torsades de Pointes) and ventricular fibrillation.
The QT interval varies with heart rate, and is usually corrected by Bazette's formula 6 :
QTc=Measured QT/√RR interval (all measured in seconds from the ECG) The QTc in a normal individual is usually less than 420 ms, but it can be affected by many physiological and pathological variables 7 . The QT interval also has variability (or "dispersion") across different leads of the ECG, however its measurement is often either standardized to lead II, which usually has the longest interval, or is taken as an average of all of the ECG leads 1, 8 .
In December 2001, the U.S. Food and Drug Administration (FDA) issued a "black box warning", that droperidol may be associated with QT prolongation and sudden cardiac death 9 . The warning restricted this commonly used premedicant and effective anti-emetic to patients who do not respond or have contraindications to other medication. Moreover, the FDA recommend that patients who receive droperidol should undergo a 12-lead ECG prior to its administration to determine if a prolonged QT interval is present, and that ECG monitoring should be continued for two to three hours after completing treatment to monitor for arrhythmias 9 . This recommendation has generated substantial debate within the anaesthetic community [10] [11] [12] .
We undertook a survey of anaesthetists in our Department to determine the extent of their knowledge of the QT interval and its implications.
METHODS
We conducted a cross-sectional survey of trainee (resident or registrar) and consultant anaesthetists in an adult university-affiliated teaching hospital. The hospital provides all types of specialized surgical and anaesthetic services, including neurosurgery, cardiothoracic surgery (heart and lung transplantations), and trauma care. All anaesthetics are administered by specialist medical practitioners or supervised trainees.
Institutional ethics committee approval was obtained, and the study questionnaire was distributed to departmental medical staff. Returns were voluntary and confidential, with all data de-identified with separate postal returns of both the anonymous questionnaire and a coded reply slip. Written instructions were given with a covering letter directing the participants to refrain from discussing the questions with colleagues or consulting published material. No incentives were offered for completion of the survey, and the surveys were distributed during departmental meetings to ensure a period of time could be set aside immediately for completion if desired. A completed response was accepted as implying informed consent.
The primary endpoint was the number of respondents who could correctly identify droperidol as being a risk factor for prolonged QT interval, and this was analysed using Chi-square and estimation of odds ratio (OR) with its 95% confidence interval (CI). The relationship between seniority (trainee or consultant, and years of training) and knowledge level was quantified using Chi-square or Spearman rank correlation (rho). A P value less than 0.05 was considered statistically significant.
RESULTS
Of 41 questionnaires distributed, 40 were completed (98% response rate) by 20 consultant anaesthetists and 20 trainees. The years of postgraduate (M.D. or M,B., B.S,) medical training and experience were: (i)=3 years (n=4), (ii) 4 years (n=4), (iii) 5 years (n=4), (iv) 6 years (n=5), (v) 7 years (n=3); and for consultant anaesthetists: (vi) 8-13 years (n=8), (vii) 14-19 years (n=5), (viii)=20 years (n=7). The majority of respondents expressed moderate to high level of confidence in interpreting the ECG (Table 1) , and this was related to years of training by Spearman rank correlation (rho 0.36, P=0.024). Less than half of the respondents (n=19) reported they sometimes looked at the QT interval; two respondents stated they occasionally looked at the computerized ECG machine's estimation of the corrected QT interval. Knowledge of the normal QT interval A total of 27 respondents (65%) were able to correctly identify the QT interval on a schematic representation of the ECG, trainees 70% vs consultants 60%, P=0.51 (Chi-square analysis). The normal QT interval at three heart rates was accepted as a QTc between 350 and 450 ms. (An upper limit of 440 ms is often quoted for men and 450 ms for women.) Most respondents either overestimated the QT interval (above the upper limit of 450 ms) or failed to provide an answer in each instance ( Table 2 ). The majority (n=29, 73%) knew that the QT interval was dependent on heart rate. Although not requested, some respondents (n=13, 33%) attempted to quote Bazette's correction equation 4 , and a few (n=5, 13%) were able to cite this correctly. Only nine respondents (23%) were able to either quote the correct Bazette formula or report a normal QT interval for all three given heart rates, trainees 25% vs consultants 15%, P=0.60 (Fisher's exact test).
Clinical importance of the QT interval
When asked to name drugs that altered the QT interval, the majority of respondents could identify at least one drug correctly (Table 3) ; 12 were correctly named by one respondent. Many respondents could name at least three correct drugs, trainees 65% vs 
DISCUSSION
The most widely publicized non-cardiac drug given by anaesthetists that is likely to prolong the QT interval is droperidol. Although the justification for the FDA black box warning for droperidol has recently been questioned [10] [11] [12] , its recommendation of monitoring the QT interval still remains a burden of responsibility for those clinicians prescribing droperidol, at least in the United States. We found that knowledge of this possible adverse effect of droperidol was poor, especially amongst trainees in anaesthesia.
There are very few recent studies examining anaesthetists' knowledge of the ECG in the published literature. Montgomery et al investigated the ability of physicians in a variety of specialties to correctly define the PR and QT intervals on an illustration of a standard ECG 13 . Only 38 of the 158 respondents (24%) were able to mark the QT interval correctly on the diagram, including 10 of 23 (43%) cardiology trainees and consultants, 1 of 7 (14%) cardiothoracic surgical trainees and consultants, and none of the emergency medicine trainees or consultants. In their study, 21 of the 28 (75%) anaesthetic trainees and consultants were unable to define a correct PR interval. The study was subsequently criticized because measurement of the PR and QT intervals were thought to be only rarely important clinical measures of ECG interpretation in the early 1990s 14 .
More recently, LaPointe et al undertook a study of physicians (38%), trainees (9%) and nurses (45%), primarily involved in cardiology (81% of responses) 15 . Despite their poor response rate of 334 from approximately 1280 questionnaires (26%), their figure of 60% of physicians able to measure a QT interval on a simulated ECG is similar to our result of 65% from anaesthetists. Their apparently better knowledge of drugs associated with QT prolongation could be due to either a cultural difference between the U.S.A. and Australia, or a difference of the knowledge between specialties. Nonetheless, the significant coverage in medical journals of QT prolongation with droperidol in both the U.S.A. and Australia should have ensured a widespread knowledge in both anaesthetic communities as to the risks with this particular drug, and the drug would have been expected to be listed by more respondents in our study.
Our survey was conducted in only one institution, and this hospital cannot be thought of as typical, as the staff regularly deal with patients with a high level of surgical complexity, including many types of cardiac anaesthesia. Nonetheless, this would be expected to overestimate the level of knowledge of the QT interval compared to the overall anaesthetic community, and the comparison with Montgomery et al's earlier study would support this. Due to the small numbers of cardiac anaesthetists and issues regarding anonymity of these few individuals, differentiation between this group and the broader group of noncardiac anaesthetists was not attempted, although this may be interesting to explore in any future larger study. Similarly a comparison between specialties and of other measurements on the ECG, such as in Montgomery et al's study would give further information as to the state of education of the anaesthetic community about the ECG as a whole.
Our study did not use real or simulated 12lead ECGs to test the ability to measure the QT interval in a clinical setting. We aimed to test theoretical knowledge which is required to perform the calculations, and consequently the results are not subject to measurement error, dispersion or beat-to-beat variability on the printed ECG 16, 17 . Previous studies using actual ECGs have highlighted the unreliability of QT interval measurement by cardiologists 16 . One could argue that it is unreasonable to expect anaesthetists to be able to detect a prolonged QT interval when both inter-and intraobserver variability exists, and indeed a suggestion has been made that only cardiac electrophysiologists can reliably recognize a prolonged QT interval 5 . The QT interval varies diurnally 18 , as well as across the 12-lead ECG 1 and under anaesthesia 17 , which further complicates the practice of monitoring a patient's ECG perioperatively. Furthermore, the QTc interval that reliably predicts the risk of the development of life-threatening ventricular arrhythmias in patients treated with drugs that prolong the QT interval is uncertain 7, 8 , although an interval over 500 ms is thought to correlate with a higher risk. For these and other reasons, there are recommended guidelines for pharmaceutical companies to test the propensity to Torsades induction during drug development 17 . These tests are very precise, are arguably beyond the skills of most anaesthetists, but are impractical for general use due to their complexity. Torsades de Pointes is an uncommon ventricular arrhythmia, but one typically associated with long QT syndrome. The mechanism for the arrhythmia involves amplification of electrical heterogeneities within the ventricular myocardium, which exist because of differences in the time course of repolarization of the three predominant cell types that make up the ventricular myocardium 2 .
There are no reports in the peer-reviewed medical literature of low-dose droperidol (i.e. less than 1.25 mg), such as would be used for the management of postoperative nausea and vomiting, causing QT prolongation or ventricular arrhythmias 11 . Droperidol is used on occasion as an anti-emetic within our institution, particularly in combination with opiate-PCA devices. Patients are not routinely monitored with serial ECGs during droperidol infusions, but may have a routine preoperative ECG, which may or may not be evaluated for a prolonged QT interval prior to droperidol administration. No adverse effects on the QT interval of the prescribing of droperidol have been reported in the authors' institution.
This survey demonstrates that within a universityaffiliated teaching hospital that regularly treats complex cardiac patients, anaesthetists have a limited practical knowledge of the QT interval, although its importance is well-recognized. Further education of both trainee and consultant anaesthetists is needed to ensure recognition of QT prolongation perioperatively, at least in this institution. We assert that practical knowledge of the QT interval by anaesthetists in the wider anaesthetic community is similarly less than that which would be expected to detect a dangerously prolonged interval preoperatively, or prior to commencing QT prolonging medications such as droperidol, as mandated by the U.S. FDA.
We propose that anaesthetic training programs and continuing education should include instruction about measurement of the QT interval to encourage the safer use of these drugs.
